Trials / Completed
CompletedNCT00191698
Comparison of Atomoxetine and Placebo in Children and Adolescents With ADHD and ODD
A Randomized, Double-Blind Comparison of Atomoxetine Hydrochloride and Placebo in Child and Adolescent Outpatients With Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 226 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 6 Years – 12 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this trial is to test the effectiveness of atomoxetine in treating symptoms of ODD in children with ADHD and ODD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | atomoxetine hydrochloride | |
| DRUG | placebo |
Timeline
- Start date
- 2003-12-01
- Primary completion
- 2005-06-01
- Completion
- 2007-11-01
- First posted
- 2005-09-19
- Last updated
- 2008-10-31
Locations
16 sites across 8 countries: Australia, Belgium, Denmark, Finland, Germany, Netherlands, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT00191698. Inclusion in this directory is not an endorsement.